Lanreotide powder (INN) is a medication used in the management of acromegaly and symptoms
caused by neuroendocrine tumors, most notably carcinoid syndrome. It is
a long-acting analogue of somatostatin, like octreotide. Its sequence
is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2.
Lanreotide is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the
management of symptoms caused by neuroendocrine tumors, particularly
carcinoid tumors and VIPomas. In the United States and Canada,
lanreotide is only indicated for the treatment of acromegaly. In the
United Kingdom, it is also indicated in the treatment of thyrotrophic
adenoma,a rare tumor of the pituitary gland which secretes TSH.
Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible
general antitumor agent.
Quick Details
CAS No.:
108736-35-2
Other Names:
Lanreotide Acetate
MF:
C54H69N11O10S2
EINECS No.:
/
Place of Origin:
Shaanxi, China
Type:
Auxiliaries and Other Medicinal Chemicals, oxytocin
Grade Standard:
Medicine Grade, Tech Grade
Brand Name:
SWY
Model Number:
SWY-1878
Purity:
99%min
Product Name:
Lanreotide Acetate
Appearance:
White crystalline powder
Molecular weight:
1096.32
Assay:
99%
Shelf life:
2 Years
Standard::
USP EP JP etc.
Storage:
Clean and Dry Place
MOQ:
1kg
Application:
Human
Payment Term:
DDU
